ROS1-mutant cancer and immune checkpoint inhibitors: A large database analysis

Lung Cancer. 2020 Dec:150:252-253. doi: 10.1016/j.lungcan.2020.08.002. Epub 2020 Aug 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adenocarcinoma of Lung
  • Albumins
  • Aminopyridines
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Immune Checkpoint Inhibitors
  • Lactams
  • Lactams, Macrocyclic
  • Lung Neoplasms* / drug therapy
  • Mutation, Missense
  • Paclitaxel
  • Protein-Tyrosine Kinases* / genetics
  • Proto-Oncogene Proteins / genetics
  • Pyrazoles

Substances

  • 130-nm albumin-bound paclitaxel
  • Albumins
  • Aminopyridines
  • Antibodies, Monoclonal, Humanized
  • Immune Checkpoint Inhibitors
  • Lactams
  • Lactams, Macrocyclic
  • Proto-Oncogene Proteins
  • Pyrazoles
  • pembrolizumab
  • Protein-Tyrosine Kinases
  • ROS1 protein, human
  • lorlatinib
  • Paclitaxel